ICPT
Adage Capital Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-438,437
| Closed | -$5.89M | – | 963 |
|
|
2023
Q1 | $5.89M | Buy |
+438,437
| New | +$5.89M | 0.01% | 687 |
|
|
2022
Q4 | – | Sell |
-50,000
| Closed | -$698K | – | 1069 |
|
|
2022
Q3 | $698K | Buy |
+50,000
| New | +$698K | ﹤0.01% | 905 |
|
|
2022
Q2 | – | Sell |
-100,000
| Closed | -$1.63M | – | 1163 |
|
|
2022
Q1 | $1.63M | Sell |
100,000
-1,133,000
| -92% | -$18.4M | ﹤0.01% | 912 |
|
|
2021
Q4 | $20.1M | Buy |
+1,233,000
| New | +$20.1M | 0.04% | 460 |
|
|
2020
Q3 | – | Sell |
-550,000
| Closed | -$26.4M | – | 827 |
|
|
2020
Q2 | $26.4M | Buy |
+550,000
| New | +$26.4M | 0.07% | 317 |
|
|
2019
Q3 | – | Sell |
-333,100
| Closed | -$26.5M | – | 769 |
|
|
2019
Q2 | $26.5M | Sell |
333,100
-171,900
| -34% | -$13.7M | 0.07% | 312 |
|
|
2019
Q1 | $56.5M | Buy |
505,000
+367,000
| +266% | +$41.1M | 0.14% | 180 |
|
|
2018
Q4 | $13.9M | Buy |
+138,000
| New | +$13.9M | 0.04% | 426 |
|
|
2015
Q4 | – | Sell |
-77,000
| Closed | -$12.8M | – | 750 |
|
|
2015
Q3 | $12.8M | Sell |
77,000
-10,000
| -11% | -$1.66M | 0.04% | 481 |
|
|
2015
Q2 | $21M | Sell |
87,000
-24,975
| -22% | -$6.03M | 0.05% | 402 |
|
|
2015
Q1 | $31.6M | Sell |
111,975
-8,025
| -7% | -$2.26M | 0.08% | 323 |
|
|
2014
Q4 | $18.7M | Buy |
120,000
+79,000
| +193% | +$12.3M | 0.05% | 417 |
|
|
2014
Q3 | $9.7M | Buy |
41,000
+26,000
| +173% | +$6.15M | 0.02% | 538 |
|
|
2014
Q2 | $3.55M | Sell |
15,000
-40,264
| -73% | -$9.53M | 0.01% | 629 |
|
|
2014
Q1 | $18.2M | Sell |
55,264
-119,736
| -68% | -$39.5M | 0.05% | 402 |
|
|
2013
Q4 | $11.9M | Sell |
175,000
-235,655
| -57% | -$16.1M | 0.03% | 494 |
|
|
2013
Q3 | $28.3M | Sell |
410,655
-27,779
| -6% | -$1.92M | 0.08% | 290 |
|
|
2013
Q2 | $19.7M | Buy |
+438,434
| New | +$19.7M | 0.06% | 361 |
|